Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) kept active in technical ratio analysis, on current situation shares price Dropped -6.58% to $0.71. The total volume of 6.71 Million shares held in the session, while on average its shares change hands 3835.31 shares.
Efficiency Evaluation in Focus
Entering into profitability analysis, the co has noticeable returns on equity ratio of -101.00%, which discloses how corporation’s management efficiently generates profit from shareholders invested money. The returns on investment very popular metric among passive investors, it stands at -112.50%, when it lies in positive figure than security is feasible for investment or goes for higher ROI stocks. To see the other side of picture, profit margin of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) stands at negative -89.50%; that indicates a firm actually every dollar of sales keeps in earnings. The -43.90% returns on assets present notable condition of firm. Mostly ROA known as a comparative measure, it is best to compare it against a firm’s previous ROA numbers or the ROA of a same firm.
Following previous ticker characteristics, Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) also run on active notice, stock price Dropped -6.58% after traded at $0.71 in most recent trading session.
PPHM has price to current year EPS stands at 6.10%. Moving toward ratio analysis, it has current ratio of 1.20 and quick ratio was calculated as 0.90. The debt to equity ratio appeared as 0.00 for seeing its liquidity position.
To find out the technical position of PPHM, Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) holds price to book ratio of 4.18 that unearth high-growth companies selling at low-growth prices, but it requires appropriate measurement approach. PPHM is presenting price to cash flow of 3.49.
Taking notice on volatility measures, price volatility of stock was 12.98% for a week and 12.59% for a month. The price volatility’s Average True Range for 14 days was 0.07. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 1.50 out of 1-5 scale with week’s performance of 2.90%. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) ‘s institutional ownership was registered as 12.60%, while insider ownership was 0.20%.